Redefining cell death: ferroptosis as a game-changer in ophthalmology
Frontiers in Immunology · 28.11.2025 · 16
DOI: 10.3389/fimmu.2025.1709354 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 28.11.2025. Verfasst von Yuan Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Ferroptosis, Eye Diseases, Ophthalmology. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 430 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ferroptosis, recently proposed as a novel type of cell death, is characterized by unique characteristics and recognition functions. It is involved in diverse physiological processes and in the onset and progression of various diseases and is characterized by reactions between reactive oxygen species (ROS) and iron-dependent lipid peroxidation. This process is finely regulated by a variety of metabolic pathways. Ferroptosis fundamentally differs from conventional cell death mechanisms such as apoptosis, necrosis, and autophagy. In recent years, research on ferroptosis in the field of ophthalmology has gradually emerged, and a large amount of evidence has shown that it is closely related to the occurrence and development of ophthalmic diseases such as age-related macular degeneration (AMD), diabetic retinopathy (DR), retinal ischemia–reperfusion injury (RIRI), retinitis pigmentosa, dry eye disease, cataracts, and glaucoma. This paper provides a comprehensive review of the latest advancements in ferroptosis within ophthalmological research and systematically describes the molecular mechanisms and pathophysiological significance of ferroptosis in the pathogenesis and progression of ophthalmic diseases. Exploring the mechanisms of ferroptosis holds promise for the delivery of novel molecular targets and therapeutic approaches to prevent and treat ophthalmic diseases. Additionally, its clinical translational and application are anticipated to surmount current therapeutic limitations and emerge as a significant direction for breakthroughs in the precision medicine era.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China.
- Department of Nanjing Tongren Eye Center, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.
- Ophthalmology Department, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun,Jilin, China.
- Chengdu Xinhua Hospital, Chengdu, China.
- School of Medicine, Southeast University, Nanjing, China.
- Deyang Hospital, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Deyang, China.
Zitieren
APA
Wei, Y., Lin, Y., Li, Y., Liu, J., Yang, Y., Chen, H., Han, Z., Wang, K., Qian, T., Ju, Y., & Zheng, W. (2025). Redefining cell death: ferroptosis as a game-changer in ophthalmology. Frontiers in Immunology, 16. https://doi.org/10.3389/fimmu.2025.1709354
Vancouver
Wei Y, Lin Y, Li Y, Liu J, Yang Y, Chen H, et al. Redefining cell death: ferroptosis as a game-changer in ophthalmology. Frontiers in Immunology. 2025;16. doi:10.3389/fimmu.2025.1709354
BibTeX
@article{Wei2025,
author = {Wei, Yuan and Lin, Yumeng and Li, Youjiaxi and Liu, Jiaxuan and Yang, Yaqi and Chen, Haoran and Han, Zhongyu and Wang, Ke and Qian, Tao and Ju, Yuan and Zheng, Wei},
title = {Redefining cell death: ferroptosis as a game-changer in ophthalmology},
journal = {Frontiers in Immunology},
year = {2025},
volume = {16},
doi = {10.3389/fimmu.2025.1709354}
}
EUVIMED